ES2981386T3 - Composición para reducir la producción de gas intestinal - Google Patents

Composición para reducir la producción de gas intestinal

Info

Publication number
ES2981386T3
ES2981386T3 ES15720121T ES15720121T ES2981386T3 ES 2981386 T3 ES2981386 T3 ES 2981386T3 ES 15720121 T ES15720121 T ES 15720121T ES 15720121 T ES15720121 T ES 15720121T ES 2981386 T3 ES2981386 T3 ES 2981386T3
Authority
ES
Spain
Prior art keywords
composition
gas production
intestinal gas
reduce intestinal
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES15720121T
Other languages
English (en)
Inventor
Neve Boris Le
Emilie Rocher
Denis Guyonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gervais Danone SA
Original Assignee
Gervais Danone SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gervais Danone SA filed Critical Gervais Danone SA
Application granted granted Critical
Publication of ES2981386T3 publication Critical patent/ES2981386T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
ES15720121T 2015-04-23 2015-04-23 Composición para reducir la producción de gas intestinal Active ES2981386T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2015/052965 WO2016170394A1 (en) 2015-04-23 2015-04-23 Composition for reducing intestinal gas production

Publications (1)

Publication Number Publication Date
ES2981386T3 true ES2981386T3 (es) 2024-10-08

Family

ID=53039935

Family Applications (1)

Application Number Title Priority Date Filing Date
ES15720121T Active ES2981386T3 (es) 2015-04-23 2015-04-23 Composición para reducir la producción de gas intestinal

Country Status (7)

Country Link
US (1) US10314867B2 (es)
EP (1) EP3285785B1 (es)
CN (1) CN107530381A (es)
DK (1) DK3285785T3 (es)
ES (1) ES2981386T3 (es)
RU (1) RU2725883C2 (es)
WO (1) WO2016170394A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013016606A2 (pt) 2010-12-31 2016-09-27 Abbott Lab processos para redução de incidência de tensão oxidante usando oligossacarídeos de leite humano, vitamina c e agentes antiflamatórios
WO2012092156A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
ES2657744T3 (es) 2011-07-22 2018-03-06 Abbott Laboratories Galactoligosacáridos para prevenir lesiones y/o promover la curación del tracto gastrointestinal
US10639319B2 (en) 2011-08-29 2020-05-05 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CN111280449B (zh) * 2020-02-11 2022-11-11 浙江华康药业股份有限公司 一种肠内缓释糖醇添加剂及其制备方法和应用
CN112206236A (zh) * 2020-08-28 2021-01-12 唐传生物科技（厦门）有限公司 一种l-阿拉伯糖抑制山梨醇肠道产气方面的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR071905A1 (es) * 2008-05-26 2010-07-21 Gervais Danone Sa Metodo para reducir borborigmos mediante la administracion de una bacteria bifidobacterium
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
BR112012010398A2 (pt) * 2009-11-02 2016-07-12 Gervais Danone Sa metodo para reduzir a inflamação gastrointestinal usando a bactéria bifidobacterium animalis ou um produto laticínio fermentado compreendendo tal bactéria
US9579353B2 (en) * 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
WO2014096901A1 (en) * 2012-12-18 2014-06-26 Compagnie Gervais Danone Strain of bifidobacterium animalis ssp. animalis

Also Published As

Publication number Publication date
DK3285785T3 (da) 2024-05-21
US20180133266A1 (en) 2018-05-17
EP3285785A1 (en) 2018-02-28
WO2016170394A1 (en) 2016-10-27
RU2017138021A3 (es) 2019-05-23
EP3285785B1 (en) 2024-02-21
CN107530381A (zh) 2018-01-02
US10314867B2 (en) 2019-06-11
RU2725883C2 (ru) 2020-07-07
RU2017138021A (ru) 2019-05-23

Similar Documents

Publication Publication Date Title
GB2570593B (en) Methods relating to intestinal organ-on-a-chip
HK1247249A1 (zh) 鼠李糖脂組合物的製備
DK3223827T3 (da) Kostfibersammensætning
ES2981386T3 (es) Composición para reducir la producción de gas intestinal
PT3334734T (pt) Forma c de avibactam sódico
GB201518792D0 (en) Production of proteins
DK3331498T3 (da) Nasalsammensætning
ES2874374T8 (es) Proceso para producir hidrógeno
BR112017027349A2 (pt) método para melhorar os benefícios de saúde
DK3233915T3 (da) Antistoffer til il-17c
DK3393254T3 (da) Sammensætning
EP3359485C0 (en) GRAPHENE PRODUCTION
BR112016021875A2 (pt) composição tópica
ES2981705T3 (es) Composiciones farmacéuticas de carotenoides
DK3322295T3 (da) Sammensætning
BR112017016240A2 (pt) composição
FI20155387A (fi) Sterolien tuottaminen
GB2538045B (en) Improvements to letter-plates
FR3031980B1 (fr) Melange thermoregulant
BR112016012168A2 (pt) Método para produzir macarrões instantâneos
BR112018000551A2 (pt) produção de d-sorbitol
BR112016024296A2 (pt) composições e métodos para aumentar a produção
CO7061051A2 (es) Ensamble de empaque para prevenir la activación prematura
ES1139057Y (es) Equipo para la produccion de gas oxhidrico
CL2015003627A1 (es) Proceso para obtener avena saborizada